findmyKOL
Clinical trialNCT05295628Active, not recruitingInterventional

Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR

SponsorEmblok, Inc.Enrollment532Aortic Valve DiseaseAortic Valve InsufficiencyAortic Valve ReplacementAortic Valve Stenosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Dignity Health Chandler Regional Medical Center

    Chandler, Arizona, United States

  • St Joseph'S Providence

    Orange, California, United States

  • Sutter Medical Center Sacramento

    Sacramento, California, United States

  • Santa Barbara Cottage Hospital

    Santa Barbara, California, United States

  • Los Robles Hospital and Medical Center

    Thousand Oaks, California, United States

  • Hartford Hospital

    Hartford, Connecticut, United States

  • Medstar Washington Hospital Center

    Washington D.C., District of Columbia, United States

  • Advocate Christ Medical Center

    Oak Lawn, Illinois, United States

  • University of Iowa Hospital and Clinics

    Iowa City, Iowa, United States

  • Ascension Via Christi Hospitals Wichita, Inc.

    Wichita, Kansas, United States

  • Cardiovascular Institute of the South

    Houma, Louisiana, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, United States

  • University of Michigan

    Ann Arbor, Michigan, United States

  • Henry Ford Hospital

    Detroit, Michigan, United States

  • Corewell Health

    Grand Rapids, Michigan, United States

  • University of Washington School of Medicine Barnes Jewish Hospital

    St Louis, Missouri, United States

  • Integris Baptist Medical Center

    Oklahoma City, Oklahoma, United States

  • Upmc Pinnacle Harrisburg

    Harrisburg, Pennsylvania, United States

  • Lankenau Medical Center

    Wynnewood, Pennsylvania, United States

  • the University of Texas Health Science Center at Houston

    Houston, Texas, United States

  • Baylor Scott and White the Heart Hospital Plano- Baylor Institute of Research

    Plano, Texas, United States

  • Methodist Hospital

    San Antonio, Texas, United States

  • Sentra Norfolk General Hospital

    Norfolk, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Oct 2023
Primary completion
6 May 2025
Completion
1 Oct 2025
Last update posted
6 Aug 2025
Registered enrollment
532
Registry id
NCT05295628

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.